Literature DB >> 11276002

Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour.

C Colpaert1, P Vermeulen, W Jeuris, P van Beest, G Goovaerts, J Weyler, P Van Dam, L Dirix, E Van Marck.   

Abstract

Early distant relapse occurs in a minority of node-negative breast cancer patients. Whether this poor prognosis can be predicted by the features of the primary tumour, or by the presence of occult metastases in the "negative" lymph nodes (LNs), remains a matter of debate. One hundred and four T(1-2)N(0)M(0) breast carcinoma patients were divided into two groups: group 1 (44%) showing early distant relapse with a median disease-free survival of 25 months, and group 2 (56%) showing no evidence of disease after a median follow-up of 91.5 months. All patients had received locoregional treatment only. All tumours were evaluated for medial/lateral location, histological type, size, grade, mitotic activity, fibrotic focus, necrosis, angiogenesis, growth pattern, and lymphatic vessel permeation. The haematoxylin and eosin-stained slides of all axillary LNs were revised and two additional levels were cut from each paraffin block for cytokeratin immunohistochemistry. In 24 patients (23%), occult metastases were found. These consisted of single cells or small clusters (SCs) in the marginal sinus in 17 patients (16%) and of larger colonies of cells in seven patients (7%). All detected metastases were smaller than 2 mm in diameter (micrometastases). There was no significant correlation between the presence of occult LN metastases (SCs or colonies) and the prognostically important features of the primary tumour. Early metastatic disease was significantly correlated with larger tumour size (p=0.02), higher histological grade (p=0.0008), mitotic activity (p<0.0001), presence of necrosis (p=0.0004), presence of fibrotic foci (p=0.0005), angiogenesis (p=0.0009), and lymphatic vessel permeation (p=0.018). Multiple logistic regression analysis showed that histological grade and the presence of a fibrotic focus were the only independent prognostic factors and that the presence of occult LN metastases was inversely correlated with early distant relapse. Prospective prognostic studies of occult LN metastases should consider the features of the primary tumour in a multivariate analysis. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11276002     DOI: 10.1002/path.829

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  23 in total

1.  Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance.

Authors:  M A den Bakker; A van Weeszenberg; A Y de Kanter; F H Beverdam; C Pritchard; Th H van der Kwast; M Menke-Pluymers
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Can axillary lymph node dissection be safely omitted for early-stage breast cancer patients with sentinel lymph node micrometastasis?

Authors:  Sameer Damle; Christine B Teal
Journal:  Indian J Surg Oncol       Date:  2011-03-25

3.  Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.

Authors:  Holm Eggemann; Atanas Ignatov; Madeleine Hetterich; Michael Gerken; Olaf Ortmann; Elisabeth C Inwald; Monika Klinkhammer-Schalke
Journal:  Breast Cancer Res Treat       Date:  2021-03-15       Impact factor: 4.872

4.  Nine years of experience with the sentinel lymph node biopsy in a single Italian center: a retrospective analysis of 1,050 cases.

Authors:  Sergio Bernardi; Serena Bertozzi; Ambrogio P Londero; Francesco Giacomuzzi; Vito Angione; Cinzia Dri; Arnalda Carbone; Roberto Petri
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

5.  Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Authors:  Igor Langer; Ulrich Guller; Carsten T Viehl; Holger Moch; Edward Wight; Felix Harder; Daniel Oertli; Markus Zuber
Journal:  Indian J Surg Oncol       Date:  2010-08-07

6.  Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis.

Authors:  P J Westenend; C J C Meurs; R A M Damhuis
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

7.  Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Authors:  Eugenio Maiorano; Meredith M Regan; Giuseppe Viale; Mauro G Mastropasqua; Marco Colleoni; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Aron Goldhirsch; Alan S Coates
Journal:  Breast Cancer Res Treat       Date:  2009-03-12       Impact factor: 4.872

Review 8.  Prognostic value of proliferation in invasive breast cancer: a review.

Authors:  P J van Diest; E van der Wall; J P A Baak
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

9.  The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer.

Authors:  Mark Davies; Ponnandai J Arumugam; Varsha I Shah; Alun Watkins; Andrew Roger Morgan; Nicholas D Carr; John Beynon
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

10.  Can axillary lymph node dissection be safely omitted for early-stage breast cancer patients with sentinel lymph node micrometastasis?

Authors:  Sameer Damle; Christine B Teal
Journal:  Ann Surg Oncol       Date:  2009-09-24       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.